Teva

Oct 12, 2017

BioDelivery Sciences Announces Patent Litigation Settlement Agreement with Teva

Oct 04, 2017

FDA Approval of Mylan's Glatiramer Acetate Will Turn the Payer Pressure On for Teva's Copaxone and Sandoz's Glatopa

Sep 22, 2017

TEVA PHARMACEUTICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - (TEVA)

Jun 02, 2017

Mylan Launches Generic Azilect® Tablets